Institutional shareholders dissatisfied with Bristol-Myers and Celgene – Seeking Alpha merger

by



[ad_1]

  1. Institutional shareholders dissatisfied with Bristol, Myers and Celgene merger
  2. An unhappy activist investor with the Bristol-Myers deal on the purchase of Celgene The Wall Street Journal
  3. Starboard Value owns 1 million shares in Bristol-Myers Squibb and met with CNBC management
  4. Bristol-Myers Squibb in Syracuse Joins OCC for WSYR On-the-Job Training
  5. Activist Targets Bristol-Myers Squibb Before Celgene Financial Times Transaction
  6. View full coverage on Google News

[ad_2]

Source link